MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Cure51 selects 10x Genomics Visium HD to drive its new drug discovery initiative

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

08 Aug 2024

Citius Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has...

Aptamer Sciences Inc.Innovative Liver Cancer Treatment AST-201

Brainomix's AI-Powered e-Lung, Developed with AstraZeneca, Improves Identification of Lung Fibrosis Patients at Risk

Hanmi Pharmaceutical Launches 'Aditams' in Mexico, Expanding into Latin America

Breakthrough in Zika Virus Drug Discovery Reported by IRBM

Tiger BioSciences Launched carePAC™: Pre-Configured Wound Care Kits for Simplified At-Home Management

By Tiger BioSciences
Tiger BioSciences
02 Apr 2026

Thermo Fisher Scientific Unveils Integrated Platform to Enhance Biologics Development

By Thermo Fisher
Thermo Fisher
02 Apr 2026

Orca Bio Announces FDA Extension of BLA Review for Orca-T in the Treatment of Hematologic Malignancies.

By Orca Bio
Orca Bio
01 Apr 2026

$CellCentric Launches DOMMINO-1, a Phase 2 Trial of Inobrodib Combined with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma$

CellCentric Launches DOMMINO-1, a Phase 2 Trial of Inobrodib Combined with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

By CellCentric
CellCentric
01 Apr 2026

ProductLife Group Appoints Dr. James Burt as CEO

By ProductLife Group
ProductLife Group
24 Mar 2026

Constance Sabbagh Appointed as General Manager as Avanzanite Expands French Operations

By Avanzanite Bioscience B.V.
Avanzanite Bioscience B.V.
24 Mar 2026

The Digital Pharma Advances Conference 2026

Most Popular

Neurophet gains FDA 510(k) clearance for Neurophet AQUA, advancing multiple sclerosis analysis with AI-driven precision

By Neurophet

Nov 25
LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome's long-term efficacy and tolerability is published in Developmental Medicine and Child Neurology

By Acadia Pharmaceuticals Inc.

Sep 16
Pint Pharma secures ANVISA approval for BESREMi® to treat Polycythemia Vera

By Pint Pharma

Mar 24

April 2026

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Cure51 selects 10x Genomics Visium HD to drive its new drug discovery initiative

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

Aptamer Sciences Inc.Innovative Liver Cancer Treatment AST-201

Brainomix's AI-Powered e-Lung, Developed with AstraZeneca, Improves Identification of Lung Fibrosis Patients at Risk

Hanmi Pharmaceutical Launches 'Aditams' in Mexico, Expanding into Latin America

Breakthrough in Zika Virus Drug Discovery Reported by IRBM

Tiger BioSciences Launched carePAC™: Pre-Configured Wound Care Kits for Simplified At-Home Management

Thermo Fisher Scientific Unveils Integrated Platform to Enhance Biologics Development

Orca Bio Announces FDA Extension of BLA Review for Orca-T in the Treatment of Hematologic Malignancies.

CellCentric Launches DOMMINO-1, a Phase 2 Trial of Inobrodib Combined with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

ProductLife Group Appoints Dr. James Burt as CEO

Constance Sabbagh Appointed as General Manager as Avanzanite Expands French Operations

Most Popular

Neurophet gains FDA 510(k) clearance for Neurophet AQUA, advancing multiple sclerosis analysis with AI-driven precision

LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome's long-term efficacy and tolerability is published in Developmental Medicine and Child Neurology

Pint Pharma secures ANVISA approval for BESREMi® to treat Polycythemia Vera

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe for e-Newsletter Monthly